Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.
A Post-Market Observational Study to Evaluate Safety and Performance of Primus™ FGT Implant at a Minimum of 5 Years Follow-up
1 other identifier
observational
70
1 country
1
Brief Summary
Foot silicone implants suffer from bad reputation on the market, due to poor results obtained with the first generations of implants. Allergies to silicone, infections due to silicone and implants breakage used to be common with previous generations of silicone implants. Publications relative to those implants showed that the survival rates after 5 years of follow-up were unsatisfactory. Since 1998, Tornier has been selling a new generation of silicone implants made of Ultrasil™. The use of this new material in its manufacturing process together with its innovative geometry, make the Primus™ FGT a much more resistant, anatomic and long lasting implant. The main objective of this study is to evaluate the clinical outcomes of the implantation of Primus™ FGT implant in great toe arthroplasty. The study will capture long term outcomes in terms of functional metrics from documented clinical data. Other objectives are to evaluate the outcomes in terms of radiological evaluation and of safety during all the follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 19, 2015
CompletedFirst Posted
Study publicly available on registry
January 30, 2015
CompletedResults Posted
Study results publicly available
October 31, 2016
CompletedOctober 31, 2016
May 1, 2016
1.1 years
January 19, 2015
May 2, 2016
September 12, 2016
Conditions
Outcome Measures
Primary Outcomes (7)
AOFAS Hallux-MTP-IP Score - Overall
AOFAS (American Orthopedic Foot and Ankle Society) Hallux-MTP-IP (Hallux-Meta-Tarso-Phalangeal-Inter-Phalangeal) score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points. The AOFAS total score is then ranging from 0 to 100 points. A result over 80 points is considered "good", below 20 points as "bad".
mean 6.9 years follow-up (range 5.2 - 9.5)
AOFAS Hallux-MTP-IP - PAIN Score
Pain is a sub-score of the AOFAS Hallux-MTP-IP score and is measured on a scale of 40 points - the higher value represents a minimal pain.
mean follow-up of 6.9 years (range, 5.2 - 9.5)
Pain at Passive Motion of MTP1
Number of patients reporting pain at passive motion of MTP1 at preoperative and postoperative visits.
mean follow-up of 6.9 years (range, 5.2 - 9.5)
Pain at Pressure of MTP1
Number of patients reporting pain at pressure of MTP1 at preoperative and postoperative visits.
mean follow-up of 6.9 years (range, 5.2 - 9.5)
Walking Perimeter
Subjective evaluation by the patients of their walking perimeter, postoperatively versus preoperatively. Patient had to choose among 3 variables : "improved", "same", "worsened".
mean follow-up of 6.9 years (range, 5.2 - 9.5)
Pain During Walking
Subjective evaluation by patients about pain during walking, postoperatively versus preoperatively. Patients had to choose among 4 variables : "disappeared", "less", same", "greater".
mean follow-up of 6.9 years (range, 5.2 - 9.5)
Pain at Rest
Subjective evaluation of patients about ther pain at rest, postoperatively versus preoperatively. Patients had to choose among 4 variables : "disappeared", "less", "same, "greater".
mean follow-up of 6.9 years (range, 5.2 - 9.5)
Secondary Outcomes (3)
Osteolysis
mean 6.9 years (range, 5.5 - 9.5)
Bone Resorption
mean 6.9 years (range, 5.5 - 9.5)
Survival of the Implant.
mean follow-up of 6.9 years (range, 5.2 - 9.5)
Interventions
Great toe arthroplasty consists of replacing the first Meta-Tarso-Phalangeal (MTP1) joint by a two hinged prosthesis made of silicone : the Primus FGT implant (FGTI). The Primus is designed with an axially offset hinge to align with the anatomy of the MTP joint. This results in less implant stresses and improved toe function.
Eligibility Criteria
This study has included all patients who had had a Primus™ FGT implantation.
You may qualify if:
- patient has had a Primus™ FGT implantation for one of the following indications: hallux limitus, hallux rigidus, hallux abducto valgus associated with severe arthritis, unstable or painful joint from previous surgery on the great toe,
- patient having all necessary clinical and radiographical data available.,
- patient has been informed about this scientific study and has provided their Consent to participate.
You may not qualify if:
- patient does not have clinical and radiographic follow-up data available.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Casa Di Cura Villa Berica
Vicenza, Vicenza, 36100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
* inclusion of patients from only 1 site, operated by a single surgeon * lack of control group for comparison with another treatment option * inability to compare preoperative and postoperative AOFAS scores
Results Point of Contact
- Title
- Dr Stefano Fieschi
- Organization
- Casa di Cura VIlla Berica
Study Officials
- PRINCIPAL INVESTIGATOR
Stefano FIESCHI, MD
Casa di Cura Villa Berica - Vicenza - Italy
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2015
First Posted
January 30, 2015
Study Start
May 1, 2013
Primary Completion
June 1, 2014
Study Completion
November 1, 2014
Last Updated
October 31, 2016
Results First Posted
October 31, 2016
Record last verified: 2016-05